Literature DB >> 24832746

Unexpectedly high recanalization rate in patients with pulmonary embolism treated with anticoagulants alone.

Raffaele Pesavento1, Lucia Filippi, Antonio Pagnan, Adriana Visonà, Paolo Pauletto, Giorgio Vescovo, Stefano Cuppini, Giampietro Beltramello, Sabina Villalta, Giorgio De Conti, Valentina Vedovetto, Anna Chiara Frigo, Paolo Prandoni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24832746     DOI： 10.1164/rccm.201312-2251LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  5 in total

1.  Incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolism.

Authors:  Ming Sheng Lim; Dee Nandurkar; Ian Jong; Anita Cummins; Huyen Tran; Sanjeev Chunilal
Journal:  J Thromb Thrombolysis       Date:  2020-02       Impact factor: 2.300

Review 2.  The value of inhibitors of factor Xa for the treatment of pulmonary embolism.

Authors:  Paolo Prandoni; Sally Temraz; Sofia Barbar; Raffaele Pesavento; Alì Taher
Journal:  Intern Emerg Med       Date:  2014-05-29       Impact factor: 3.397

Review 3.  Current concepts in the pathogenesis of chronic thromboembolic pulmonary hypertension.

Authors:  Daniel T Matthews; Anna R Hemnes
Journal:  Pulm Circ       Date:  2016-06       Impact factor: 3.017

4.  Factors determining altered perfusion after acute pulmonary embolism assessed by quantified single-photon emission computed tomography-perfusion scan.

Authors:  Marc Meysman; Hendrik Everaert; Walter Vincken
Journal:  Ann Thorac Med       Date:  2017 Jan-Mar       Impact factor: 2.219

5.  Computed tomography pulmonary embolism residua index (CTPER-index): a simple tool for pulmonary embolism residua description.

Authors:  Zdenek Vavera; Pavel Elias; Pavel Ryska; Jan Vojacek
Journal:  Anatol J Cardiol       Date:  2015-05-06       Impact factor: 1.596
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.